Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 5, 2010, Pages 964-969

  Wang, Jing Houng ^a   Changchien, Chi Sin ^a   Hung, Chao Hung ^a   Tung, Wei Chih ^a   Kee, Kwong Ming ^a   Chen, Chien Hung ^a   Hu, Tsung Hui ^a   Lee, Chuan Mo ^a   Lu, Sheng Nan ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Chronic hepatitis C; Interferon based therapy; Transient elastography

Indexed keywords

INTERFERON; RIBAVIRIN; ANTIVIRUS AGENT; PEGINTERFERON; VIRUS RNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; EQUIPMENT; FEMALE; HEPATITIS C; HUMAN; LIVER FIBROSIS; LIVER HISTOLOGY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; RIGIDITY; BODY MASS; CHRONIC HEPATITIS C; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EFFICACY; ELASTOGRAPH; ELASTOGRAPHY; LIVER BIOPSY; LIVER DISEASE; LIVER FUNCTION; LIVER STIFFNESS; MEASUREMENT; MIDDLE AGED; NON SUSTAINED VIROLOGICAL RESPONSE; PREDICTIVE VALUE; RISK FACTOR; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT DURATION; TREATMENT RESPONSE; VIROLOGY; BLOOD; COMPLICATION; DRUG COMBINATION; DRUG EFFECTS; ECHOGRAPHY; ELASTICITY; GENETICS; HEPACIVIRUS; HEPATITIS C, CHRONIC; LIVER; LIVER CIRRHOSIS; SEVERITY OF ILLNESS INDEX; TAIWAN; TIME; TREATMENT OUTCOME; VIRUS LOAD;

ANTIVIRAL AGENTS; BODY MASS INDEX; DRUG THERAPY, COMBINATION; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LIVER; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RIBAVIRIN; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; TAIWAN; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 77951762749     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.06194.x     Document Type: Article

References (35)

1. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004 39 : 1147 1171.
2. Ryder SD, Irving WL, Jones DA, Neal KR, Underwood JC, Trent Hepatitis C Study Group. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 2004 53 : 451 455.
3. Bravo A, Sheth S, Chopra S. Liver biopsy. N. Engl. J. Med. 2001 344 : 495 500.
4. Regev A, Berho M, Jeffers LJ et al. Sampling error and inter-observer variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 2002 97 : 2614 2618.
5. Bedossa P, Dalgere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003 38 : 1449 1457. (Pubitemid 37466971)
6. Mukherjee S, Sorrell MF. Noninvasive tests for liver fibrosis. Semin. Liver Dis. 2006 26 : 337 347.
7. Sandrin L, Fourquet B, Hasquenoph JM et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol. 2003 29 : 1705 1713.
8. Kettaneh A, Marcellin P, Douvin C et al. Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J. Hepatol. 2007 46 : 628 634.
9. Fraquelli M, Rigamonti C, Casazza G et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007 56 : 968 973.
10. Castera L, Vergniol J, Foucher J et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterolgy 2005 128 : 343 350.
11. Ziol M, Handra-Luca A, Kettaneh A et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005 41 : 48 54.
12. Shaheen AAM, Wan AF, Myers RP. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systemic review of diagnostic test accuracy. Am. J. Gastroenterol. 2007 102 : 2589 2600.
13. Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systemic review and meta-analysis. Clin. Gastroenterol. Hepatol. 2007 5 : 1214 1220.
14. Friedrich-Rust M, Ong MF, Martens S et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008 134 : 960 974.
15. Barreiro P, Labarga P, Martin-Carbonero L et al. Sustained virological response following HCV therapy is associated with non-progression of liver fibrosis in HCV/HIV-coinfected patients. Antivir. Ther. 2006 11 : 869 877.
16. Vergniol J, Foucher J, Castera L et al. Changes of non-invasive markers and FibroScan values during HCV treatment. J. Viral Hepat. 2009 16 : 132 140.
17. Shiratori Y, Imazeki F, Moriyama M et al. Histologic improvement of fibrosis in patients with chronic hepatitis C who have sustained response to interferon therapy. Ann. Int. Med. 2000 132 : 517 524.
18. Hung CH, Kuo FY, Wang JH et al. Impact of steatosis on long-term histological outcome in chronic hepatitis C after antiviral therapy. Antivir. Ther. 2006 11 : 483 489.
19. Poynard T, Imbert-Bismut F, Ratziu V et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J. Viral Hepat. 2002 9 : 128 133.
20. Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology 2003 38 : 481 492.
21. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management and treatment of hepatitis C. Hepatology 2004 39 : 1147 1171.
22. Wright M, Grieve R, Roberts J, Main J, Thomas J. UK mild hepatitis C trial investigator. Health benefits of antiviral therapy for mild chronic hepatitis C: randomized controlled trial and economic evaluation. Health Technol. Assess. 2006 10 : 1 113.
23. Lee CM, Lu SN, Hung CH et al. Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications. Trans. R. Soc. Trop. Med. 2006 100 : 767 774.
24. Yu ML, Dai CY, Huang JF et al. A randomized study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C. Gut 2007 56 : 553 559.
25. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. The practice guidelines committee of the American Association for the Study of Liver Diseases, The practice parameters committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007 46 : 922 938.
26. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005 42 : 1208 1236.
27. Hung CH, Lee CM, Lu SN et al. Long-term effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. J. Viral. Hepat. 2006 13 : 409 414.
28. Yu ML, Huang CF, Dai CY, Huang JF, Chuang WL. Long-term effects of interferon-based therapy for chronic hepatitis C. Oncology 2007 72 (Suppl. 1 16 23.
29. Poynard T, McHutchison J, Manns M et al. Impact of pegylated alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002 122 : 1303 1313. (Pubitemid 34465173)
30. Wang JH, Changchien CS, Hung CH et al. FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis. J. Gastroenterol. 2009 44 : 439 446.
31. Foucher J, Chanteloup E, Vergniol J et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006 55 : 403 408.
32. Kazemi F, Kettaneh A, N'kontchou G et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J. Hepatol. 2006 45 : 230 235.
33. Arena U, Vizzutti F, Corti G et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008 47 : 380 384.
34. Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for diagnosis of cirrhosis in patients with acute liver damage. Hepatology 2008 47 : 592 595.
35. Coco B, Oliveri F, Maina AM et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J. Viral Hepat. 2007 14 : 360 369.